← Evidence map

ReviewBiomedicines2022

The Performance of FDA-Approved PET Imaging Agents in the Detection of Prostate Cancer.

Mei Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

14 papers cite it

2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 36289795